共 50 条
- [27] Elevated Serum ELABELA and SERPINA3 as Novel Biomarkers to Predict Poor Prognosis in Egyptian Chronic Lymphocytic Leukemia Patients CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S272 - S272
- [29] Elevated serum ELABELA and SERPINA3 as novel biomarkers to predict poor prognosis in Egyptian chronic lymphocytic leukemia patients EGYPTIAN JOURNAL OF HAEMATOLOGY, 2023, 48 (02): : 191 - 200